Premier Biomedical Stock Buy Hold or Sell Recommendation
| BIEI Stock | USD 0.0009 0.0001 10.00% |
Given the investment horizon of 90 days and your slightly conservative level of risk, our recommendation regarding Premier Biomedical is 'Strong Sell'. The recommendation algorithm takes into account all of Premier Biomedical's available fundamental, technical, and predictive indicators you will find on this site.
Check out Premier Biomedical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Premier and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Premier Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
Premier |
Execute Premier Biomedical Buy or Sell Advice
The Premier recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Premier Biomedical. Macroaxis does not own or have any residual interests in Premier Biomedical or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Premier Biomedical's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Responds to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Premier Biomedical Trading Alerts and Improvement Suggestions
| Premier Biomedical generated a negative expected return over the last 90 days | |
| Premier Biomedical has high historical volatility and very poor performance | |
| Premier Biomedical has some characteristics of a very speculative penny stock | |
| Premier Biomedical has a very high chance of going through financial distress in the upcoming years | |
| Premier Biomedical currently holds 160.75 K in liabilities. Premier Biomedical has a current ratio of 0.05, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Premier Biomedical until it has trouble settling it off, either with new capital or with free cash flow. So, Premier Biomedical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Premier Biomedical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Premier to invest in growth at high rates of return. When we think about Premier Biomedical's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 14.28 K. Net Loss for the year was (374.47 K) with profit before overhead, payroll, taxes, and interest of 1.42 K. | |
| Premier Biomedical currently holds about 71.2 K in cash with (344.18 K) of positive cash flow from operations. | |
| Latest headline from investing.com: Forte Biosciences CFO acquires 124,997 in company stock |
Premier Biomedical Returns Distribution Density
The distribution of Premier Biomedical's historical returns is an attempt to chart the uncertainty of Premier Biomedical's future price movements. The chart of the probability distribution of Premier Biomedical daily returns describes the distribution of returns around its average expected value. We use Premier Biomedical price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Premier Biomedical returns is essential to provide solid investment advice for Premier Biomedical.
| Mean Return | 0.16 | Value At Risk | -16.67 | Potential Upside | 21.43 | Standard Deviation | 11.03 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Premier Biomedical historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Premier Biomedical Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Premier Biomedical or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Premier Biomedical's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Premier pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.04 | |
β | Beta against Dow Jones | 1.56 | |
σ | Overall volatility | 10.66 | |
Ir | Information ratio | 0 |
Premier Biomedical Volatility Alert
Premier Biomedical is showing large volatility of returns over the selected time horizon. Premier Biomedical appears to be a penny stock. Although Premier Biomedical may be, in fact, a solid short-term or long term investment, many penny pink sheets are speculative investment instruments that are often subject to artificial stock promotion and campaigns of hype which may lead to misinformation and misrepresentation. Please make sure you fully understand upside potential and downside risks of investing in Premier Biomedical or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswing without any event/news,and sudden news releases. We also encourage traders to check biographies and work history of company President, CEO or other officers before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Premier instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Premier Biomedical Fundamentals Vs Peers
Comparing Premier Biomedical's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Premier Biomedical's direct or indirect competition across all of the common fundamentals between Premier Biomedical and the related equities. This way, we can detect undervalued stocks with similar characteristics as Premier Biomedical or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Premier Biomedical's fundamental indicators could also be used in its relative valuation, which is a method of valuing Premier Biomedical by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Premier Biomedical to competition |
| Fundamentals | Premier Biomedical | Peer Average |
| Return On Asset | -1.54 | -0.14 |
| Operating Margin | (22.88) % | (5.51) % |
| Current Valuation | 1.6 M | 16.62 B |
| Shares Outstanding | 999.98 M | 571.82 M |
| Shares Owned By Insiders | 2.36 % | 10.09 % |
| Price To Earning | 0.07 X | 28.72 X |
| Price To Sales | 112.03 X | 11.42 X |
| Revenue | 14.28 K | 9.43 B |
| Gross Profit | 1.42 K | 27.38 B |
| EBITDA | 20.91 K | 3.9 B |
| Net Income | (374.47 K) | 570.98 M |
| Cash And Equivalents | 71.2 K | 2.7 B |
| Total Debt | 160.75 K | 5.32 B |
| Debt To Equity | (1.18) % | 48.70 % |
| Current Ratio | 0.05 X | 2.16 X |
| Book Value Per Share | (0.01) X | 1.93 K |
| Cash Flow From Operations | (344.18 K) | 971.22 M |
| Earnings Per Share | (0.01) X | 3.12 X |
| Number Of Employees | 11 | 18.84 K |
| Beta | -4.63 | -0.15 |
| Market Capitalization | 4.3 M | 19.03 B |
| Total Asset | 100.94 K | 29.47 B |
| Retained Earnings | (3.91 M) | 9.33 B |
| Working Capital | (279.97 K) | 1.48 B |
| Current Asset | 44.58 K | 9.34 B |
| Current Liabilities | 324.55 K | 7.9 B |
| Z Score | -40.0 | 8.72 |
| Net Asset | 100.94 K |
Premier Biomedical Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Premier . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.9 | |||
| Day Median Price | 9.0E-4 | |||
| Day Typical Price | 9.0E-4 | |||
| Price Action Indicator | (0.00005) | |||
| Period Momentum Indicator | (0.0001) | |||
| Relative Strength Index | 69.55 |
About Premier Biomedical Buy or Sell Advice
When is the right time to buy or sell Premier Biomedical? Buying financial instruments such as Premier Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Premier Biomedical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Munis Funds Thematic Idea Now
Munis Funds
Funds or Etfs that invest in fixed income securities issued by states, cities, and towns as well as other public entities. The Munis Funds theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Munis Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Premier Pink Sheet
Premier Biomedical financial ratios help investors to determine whether Premier Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Premier with respect to the benefits of owning Premier Biomedical security.